Next Article in Journal
Mitomycin C as an Anti-Persister Strategy against Klebsiella pneumoniae: Toxicity and Synergy Studies
Previous Article in Journal
Genomic Insights into Pediococcus pentosaceus ENM104: A Probiotic with Potential Antimicrobial and Cholesterol-Reducing Properties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497

1
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Health Information Technology Department, Applied College, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Family and Community Medicine Department, Faculty of Medicine in Rabigh, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4
Botany and Microbiology Department, Faculty of Science, Benha University, Benha 13518, Egypt
5
Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA
6
King Fahd Medical Research Center, Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Authors to whom correspondence should be addressed.
Antibiotics 2024, 13(9), 814; https://doi.org/10.3390/antibiotics13090814
Submission received: 1 August 2024 / Accepted: 16 August 2024 / Published: 28 August 2024
The journal retracts the article, “Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa”, cited above.
Following publication, concerns were brought to the attention of the publisher regarding an overlap of the images.
Adhering to our complaints procedure, an investigation was conducted that confirmed the overlap of Figure 8C with a figure in a previously published article [1], listing different experimental conditions. While the authors fully cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the overlap of the figures or meet the required quality standards for raw images in order to consider a correction as per the journal’s original image requirements policy (https://www.mdpi.com/journal/antibiotics/instructions#oriimages). As a result, the Editorial Board and Editor-in-Chief have lost confidence in the validity of the findings and decided to retract this paper as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Antibiotics.
The authors have agreed to this retraction.

Reference

  1. Teklemariam, A.D.; Al-Hindi, R.R.; Alharbi, M.G.; Alotibi, I.; Azhari, S.A.; Qadri, I.; Alamri, T.; Esmael, A.; Harakeh, S. RETRACTED: Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Teklemariam, A.D.; Al-Hindi, R.R.; Alharbi, M.G.; Alotibi, I.; Azhari, S.A.; Qadri, I.; Alamri, T.; Esmael, A.; Harakeh, S. RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497. Antibiotics 2024, 13, 814. https://doi.org/10.3390/antibiotics13090814

AMA Style

Teklemariam AD, Al-Hindi RR, Alharbi MG, Alotibi I, Azhari SA, Qadri I, Alamri T, Esmael A, Harakeh S. RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497. Antibiotics. 2024; 13(9):814. https://doi.org/10.3390/antibiotics13090814

Chicago/Turabian Style

Teklemariam, Addisu D., Rashad R. Al-Hindi, Mona G. Alharbi, Ibrahim Alotibi, Sheren A. Azhari, Ishtiaq Qadri, Turki Alamri, Ahmed Esmael, and Steve Harakeh. 2024. "RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497" Antibiotics 13, no. 9: 814. https://doi.org/10.3390/antibiotics13090814

APA Style

Teklemariam, A. D., Al-Hindi, R. R., Alharbi, M. G., Alotibi, I., Azhari, S. A., Qadri, I., Alamri, T., Esmael, A., & Harakeh, S. (2024). RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497. Antibiotics, 13(9), 814. https://doi.org/10.3390/antibiotics13090814

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop